Summary

U.S. Oxygen Concentrator Market Summary

The U.S. oxygen concentrator market size was estimated at USD 1.55 billion in 2024 and is projected to reach USD 3.09 billion by 2033, growing at a CAGR of 7.6% from 2025 to 2033. The increase in the prevalence of respiratory conditions such as COPD, asthma, and sleep apnea, rising healthcare spending, significant investment in R&D, advanced healthcare infrastructure, access to the newest technology, and new product launches.

According to the analyzed Medicare claims data, the Medicare penetration rate for portable oxygen concentrators (POCs) in the U.S. has steadily risen. For instance, in 2021, the POC penetration was 22.0%, while that of stationary was 17%. This is a developing trend favoring portable oxygen concentrators (POCs) over fixed oxygen concentrators and fueling the expansion of the U.S. oxygen concentrator industry.

Government support, such as the Federal Aviation Administration's (FAA) approval of portable concentrators during plane travel, further drives the region's growth. Furthermore, favorable reimbursement policies have enhanced the attractiveness of the U.S. oxygen concentrators market. For instance, in March 2024, a U.S. Congressman introduced the Supplemental Oxygen Access Reform (SOAR) Act to reform and improve access to supplementary oxygen for Medicare beneficiaries. These policies have increased the adoption of oxygen concentrators in the U.S. In addition, rising healthcare spending in the U.S. is driving the demand for effective diagnosis and treatment of respiratory diseases, thereby boosting the market for oxygen concentrators.

The rising prevalence of chronic respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), is a key driver of the U.S. oxygen concentrator market. With COPD affecting over 5% of U.S. adults and contributing to nearly USD 50 billion in annual economic costs, the demand for effective oxygen therapy solutions continues to grow. Long-term oxygen therapy has been clinically proven to improve outcomes in hypoxemic patients, making oxygen concentrators an essential part of disease management.

Moreover, limitations of traditional oxygen delivery methods, such as stationary systems and oxygen cylinders that restrict mobility and require frequent refills, accelerate the shift toward portable oxygen concentrators. These devices provide patients with greater independence and flexibility while addressing the increasing burden of COPD, cystic fibrosis, and heart failure-related hypoxemia, thereby fueling adoption across the U.S. market.

U.S. Oxygen Concentrator Market Report Segmentation

This report forecasts volume & revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. oxygen concentrator market report based on product, application, and technology:

• Product Outlook (Volume, Unit; Revenue, USD Million, 2021 - 2033)
• Portable Medical Oxygen Concentrators
• Fixed Medical Oxygen Concentrators
• Application Outlook (Volume, Unit; Revenue, USD Million, 2021 - 2033)
• Home Care
• Non-Home Care
• Technology Outlook (Volume, Unit; Revenue, USD Million, 2021 - 2033)
• Continuous Flow
• Pulse Flow

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Technology
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Increase in the prevalence of respiratory conditions such as COPD, asthma, and sleep apnea.
3.2.3. Growing adoption of home healthcare
3.2.4. Technological advancements in oxygen concentrators
3.2.5. Launch of new generation products and increasing business expansion
3.2.6. Market Restraint Analysis
3.2.7. High cost associated with oxygen concentrators
3.2.8. Industry Opportunity Analysis
3.2.9. Industry Challenge Analysis
3.2.10. Case Studies
3.3. Business Environment Analysis
3.3.1. Porter’s Five Forces Analysis
3.3.2. Supplier power
3.3.3. Buyer power
3.3.4. Substitution threat
3.3.5. Threat of new entrant
3.3.6. Competitive rivalry
3.3.7. PESTLE Analysis
3.3.8. Political landscape
3.3.9. Economic and Social landscape
3.3.10. Technological landscape
3.3.11. Environmental landscape
3.3.12. Legal Landscape
Chapter 4. U.S. Oxygen Concentrator Systems Market: Product Estimates & Trend Analysis
4.1. Product Segment Dashboard
4.2. Product Market Share Movement Analysis, 2024 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million, Unit Volume 000')
4.4. Portable Medical Oxygen Concentrators
4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
4.4.2. Market estimates and forecast 2021 to 2033 (Unit Volume 000')
4.5. Fixed Medical Oxygen Concentrators
4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
4.5.2. Market estimates and forecast 2021 to 2033 (Unit Volume 000')
Chapter 5. U.S. Oxygen Concentrator Market: Application Estimates & Trend Analysis
5.1. Application Segment Dashboard
5.2. Application Market Share Movement Analysis, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Home Care
5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
5.5. Non-Home Care
5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
Chapter 6. U.S. Oxygen Concentrator Market: Technology Estimates & Trend Analysis
6.1. Technology Segment Dashboard
6.2. Technology Market Share Movement Analysis, 2024 & 2033
6.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
6.4. Continuous flow
6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
6.5. Pulse Flow
6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
Chapter 7. U.S. Oxygen Concentrator Market: Competitive Landscape
7.1. Participant Overview
7.2. Company Market Share Analysis (2021 - 2024), by product type
7.2.1. Portable Medical Oxygen Concentrators (Value USD Million)
7.2.2. Fixed Medical Oxygen Concentrators (Value USD Million)
7.3. Volume Analysis with ASP Trends (2021 - 2024) at oxygen concentrators
7.3.1. Portable Medical Oxygen Concentrators (Unit Volume 000')
7.3.2. Fixed Medical Oxygen Concentrators (Unit Volume 000')
7.4. Company Categorization
7.5. Strategy Mapping
7.6. Company Profiles/Listing
7.6.1. Respironics (a subsidiary of Koninklijke Philips N.V.) {Effective from January 25, 2024, Philips Respironics halted the sale of their POCs, with end of service scheduled for January 25, 2029.}
7.6.1.1. Overview
7.6.1.2. Financial performance
7.6.1.3. Products benchmarking
7.6.1.4. Strategic initiatives
7.6.2. Direct Supply
7.6.2.1. Overview
7.6.2.2. Financial performance
7.6.2.3. Products benchmarking
7.6.2.4. Strategic initiatives
7.6.3. GF Health Products, Inc.
7.6.3.1. Overview
7.6.3.2. Financial performance
7.6.3.3. Products benchmarking
7.6.3.4. Strategic initiatives
7.6.4. MedaCure Inc.
7.6.4.1. Overview
7.6.4.2. Financial performance
7.6.4.3. Products benchmarking
7.6.4.4. Strategic initiatives
7.6.5. Nidek Medical Products, Inc
7.6.5.1. Overview
7.6.5.2. Financial performance
7.6.5.3. Products benchmarking
7.6.5.4. Strategic initiatives
7.6.6. O2 Concepts
7.6.6.1. Overview
7.6.6.2. Financial performance
7.6.6.3. Products benchmarking
7.6.6.4. Strategic initiatives
7.6.7. React Health
7.6.7.1. Overview
7.6.7.2. Financial performance
7.6.7.3. Products benchmarking
7.6.7.4. Strategic initiatives
7.6.8. CAIRE Inc. (Acquired by Niterra Co., Ltd., formerly known as NGK SPARK PLUG CO., LTD.)
7.6.8.1. Overview
7.6.8.2. Financial performance
7.6.8.3. Products benchmarking
7.6.8.4. Strategic initiatives
7.6.9. DeVilbiss Healthcare (a subsidiary of Drive Medical)
7.6.9.1. Overview
7.6.9.2. Financial performance
7.6.9.3. Products benchmarking
7.6.9.4. Strategic initiatives
7.6.10. GCE Group
7.6.10.1. Overview
7.6.10.2. Financial performance
7.6.10.3. Products benchmarking
7.6.11. Compass Health Brands
7.6.11.1. Overview
7.6.11.2. Financial performance
7.6.11.3. Products benchmarking